What is SPARTAN trial?
The SPARTAN trial was a Phase 3, randomized, double-blind, placebo-controlled, multicenter study that evaluated ERLEADA® plus androgen-deprivation therapy (ADT) in patients with nmCRPC who had a prostate-specific antigen (PSA) doubling time less than or equal to 10 months.
What does abiraterone therapy do?
Abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that has spread to other parts of the body. Abiraterone is in a class of medications called androgen biosynthesis inhibitors. It works by decreasing the amount of certain hormones in the body.
What company makes xtandi?
About the Pfizer/Astellas Collaboration The companies jointly commercialize XTANDI in the United States and Astellas has responsibility for manufacturing and all additional regulatory filings globally, as well as commercializing XTANDI outside the United States.
Who makes Apalutamide?
The study was sponsored by Janssen Pharmaceutical Companies, the manufacturer of apalutamide. The median length of time from the start of treatment to when tumors spread or the patient died (metastasis-free survival) was 16 months in the placebo group and 40 months in the apalutamide group.
When should Apalutamide be stopped?
Your doctor may tell you to stop taking apalutamide for a short time or decrease your dose if you experience serious side effects during your treatment. Be sure to talk to your doctor about how you are feeling during your treatment with apalutamide.
How long can you live on abiraterone?
Life expectancy: The studies show that abiraterone acetate can prolong life. In the larger study, about 50 out of 100 men who had the standard treatment were still alive after 3 years, while after the same period of time 70 out of 100 men who had treatment with abiraterone acetate were still alive.
How long does it take for abiraterone to lower PSA?
By the end of six 28-day cycles of treatment, 87% (106/122) of patients showed a PSA reduction of ≥50% and 60% (73/122) achieved a ≥90% PSA reduction. The PSA progression-free rates at 12, 18, and 24 months were estimated at 82.4%, 73.5%, and 62.8%, respectively.
Is Xtandi a type of chemotherapy?
XTANDI is an androgen receptor inhibitor; it is not a chemotherapy. Androgens are a group of hormones that includes testosterone. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.
How long can you stay on Xtandi?
In the AFFIRM trial, treatment with Xtandi extended life by almost 5 months. Treatment with Xtandi resulted in a median overall survival time of 18.4 months (95% CI 17.3 to not yet reached) compared with 13.6 months (95% CI 11.3 to 15.8) in the placebo recipients (p<0.001).
What is the difference between bicalutamide and apalutamide?
Apalutamide binds AR in the same ligand-binding domain as bicalutamide but with greater affinity, and unlike bicalutamide, retains full antagonist activity in the setting of AR overexpression (48). Furthermore, apalutamide was shown to be selective for AR over other nuclear hormone receptors (48).
Is Erleada a new drug?
Erleada First Treatment for Nonmetastatic Prostate Cancer Apalutamide, a new-generation oral androgen receptor inhibitor, is the first nonhormone therapy drug to receive FDA approval for the treatment of nonmetastatic CRPC.
How long do people stay on Erleada?
Erleada (apalutamide) is usually taken until cancer progresses past a certain point or you start to have unacceptable side effects. In the SPARTAN clinical trial (NCT01946204) using apalutamide for men with castration-resistant metastasis-free prostate cancer, some patients were still using apalutamide at 36 months.
How long does Erleada stay in system?
In 78% of men who took Erleada, their rash went away during the study. On average, it took about 78 days after the rash appeared for it to go away. If you have any skin changes while you’re taking Erleada, talk with your doctor. They may be able to recommend ways to help reduce your symptoms.
Can abiraterone stop working?
After some months or years the hormone treatment usually stops working and the cancer starts to grow again. Your doctor might recommend stopping or changing hormone treatment at this stage. If you’re having anti androgens and your PSA level has started to rise again your doctor might get you to stop taking them.
How long should I take abiraterone?
by Drugs.com Zytiga (abiraterone acetate) is a hormone therapy taken in combination with prednisone to treat prostate cancer that has already spread (metastasized) to other parts of the body. Patients typically take medications such as Zytiga for as long as they are effective for or as long as they can tolerate them.
How long can you live taking Xtandi?
Treatment with Xtandi resulted in a median overall survival time of 18.4 months (95% CI 17.3 to not yet reached) compared with 13.6 months (95% CI 11.3 to 15.8) in the placebo recipients (p<0.001).
Is Xtandi a good drug?
By Year 4, the Xtandi group showed a 70.6% overall survival rate compared with just 57% for placebo. The study showed Xtandi, used alongside the AD therapy, slashed the risk of death by 34% compared with the AD therapy alone.
Is Xtandi a form of chemo?
Is there an alternative to bicalutamide?
Amongst the anti-androgens, Casodex® (bicalutamide) is the preferred choice. It is often used at a dose of 150 mg (three 50 mg pills) daily. Another alternative is flutamide (Eulexin®) which is less expensive.